Pharmaceutical Preparations
6 companies analysed from SEC EDGAR filings. Compare valuations, profitability, and risk across the sector.
Companies
6
Total mkt cap
—
Sector P/E (ETF)
—
Avg gross margin
40.3%
Strong / Positive
2
Caution / At Risk
0
Metrics comparison
| Company | Mkt Cap↓ | P/E (vs sector) | Gross Margin | Net Margin | D/E Ratio | Risks |
|---|---|---|---|---|---|---|
| LLYELI LILLY AND COMPANY | — | — | — | 31.7% | 1.11 | — |
| MRKMerck & Co., Inc. | — | — | — | 28.1% | 0.89 | — |
| ABTABBOTT LABORATORIES | — | — | 9.9% | 14.7% | 0.25 | 1 |
| BMYBRISTOL-MYERS SQUIBB COMPANY | — | — | 63.8% | 14.6% | 2.43 | 1 |
| ABBVABBVIE INC. | — | — | 19.7% | 6.9% | — | 1 |
| JNJJohnson & Johnson | — | — | 67.9% | 28.5% | 0.51 | 1 |